NCT03984799View on ClinicalTrials.gov

Interleukin-5 Receptor Expression in COPD

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

April 30, 2022

Conditions
COPD
Interventions
PROCEDURE

Bronchoscopy

Samples obtained during bronchoscopy and blood samples will be evaluated to define inflammatory markers of COPD

Trial Locations (1)

22908

University of Virginia, Charlottesville

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Virginia

OTHER

NCT03984799 - Interleukin-5 Receptor Expression in COPD | Biotech Hunter | Biotech Hunter